NOVOCURE LTD's ticker is NVCR and the CUSIP is G6674U108. A total of 309 filers reported holding NOVOCURE LTD in Q1 2022. The put-call ratio across all filers is 1.53 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $71,417,448 | -1.4% | 973,653 | +2.1% | 0.02% | -10.5% |
| Q3 2022 | $72,451,717 | +13.4% | 953,563 | +3.7% | 0.02% | +11.8% |
| Q2 2022 | $63,900,385 | -13.6% | 919,430 | +3.0% | 0.02% | +6.2% |
| Q1 2022 | $73,981,819 | +13.5% | 892,961 | +2.8% | 0.02% | +23.1% |
| Q4 2021 | $65,187,000 | -31.8% | 868,238 | +5.6% | 0.01% | -38.1% |
| Q3 2021 | $95,525,000 | -46.8% | 822,289 | +1.5% | 0.02% | -46.2% |
| Q2 2021 | $179,697,000 | +67.4% | 810,103 | -0.3% | 0.04% | +56.0% |
| Q1 2021 | $107,348,000 | -27.6% | 812,134 | -5.2% | 0.02% | -28.6% |
| Q4 2020 | $148,269,000 | +61.1% | 856,846 | +3.6% | 0.04% | +45.8% |
| Q3 2020 | $92,047,000 | +108.2% | 826,947 | +10.9% | 0.02% | +84.6% |
| Q2 2020 | $44,220,000 | -15.6% | 745,693 | -4.1% | 0.01% | -31.6% |
| Q1 2020 | $52,370,000 | -20.1% | 777,693 | 0.0% | 0.02% | +5.6% |
| Q4 2019 | $65,536,000 | +12.7% | 777,693 | 0.0% | 0.02% | 0.0% |
| Q3 2019 | $58,156,000 | +15.5% | 777,693 | -2.3% | 0.02% | +12.5% |
| Q2 2019 | $50,345,000 | +18.9% | 796,220 | -9.4% | 0.02% | +14.3% |
| Q1 2019 | $42,334,000 | +48.7% | 878,835 | +3.3% | 0.01% | +27.3% |
| Q4 2018 | $28,472,000 | -33.8% | 850,410 | +3.6% | 0.01% | -21.4% |
| Q3 2018 | $43,004,000 | +81.0% | 820,684 | +8.1% | 0.01% | +75.0% |
| Q2 2018 | $23,756,000 | +43.6% | 758,998 | 0.0% | 0.01% | +33.3% |
| Q1 2018 | $16,546,000 | +46.4% | 758,998 | +35.7% | 0.01% | +50.0% |
| Q4 2017 | $11,299,000 | +26.7% | 559,342 | +24.5% | 0.00% | +33.3% |
| Q3 2017 | $8,917,000 | +445.4% | 449,220 | +297.9% | 0.00% | +200.0% |
| Q1 2016 | $1,635,000 | -2.5% | 112,900 | +50.5% | 0.00% | 0.0% |
| Q4 2015 | $1,677,000 | – | 75,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Invus Financial Advisors, LLC | 470,884 | $39,681,000 | 20.12% |
| HARTLINE INVESTMENT CORP/ | 330,672 | $27,866,000 | 5.97% |
| MORGAN JESS S & CO INC | 52,889 | $4,457,000 | 4.37% |
| Darsana Capital Partners LP | 1,350,000 | $113,765,000 | 3.88% |
| Rhenman & Partners Asset Management AB | 350,000 | $29,495,000 | 3.23% |
| COURAGE CAPITAL MANAGEMENT LLC | 10,000 | $843,000 | 2.55% |
| Taylor Frigon Capital Management LLC | 38,073 | $3,208,000 | 2.21% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 35,500 | $2,991,000 | 1.08% |
| Granite Investment Partners, LLC | 261,315 | $22,021,000 | 1.04% |
| Nicholas Investment Partners, LP | 85,835 | $7,233,000 | 0.74% |